Suppression of nitric oxide production by cyclosporin A and FK506A in rat vascular smooth muscle cells
- PMID: 7521274
- DOI: 10.1111/j.1440-1681.1994.tb02503.x
Suppression of nitric oxide production by cyclosporin A and FK506A in rat vascular smooth muscle cells
Abstract
1. The effects of the immunosuppressants cyclosporin A (CsA) and FK506 on nitric oxide (NO) synthesis induced by lipopolysaccharide (LPS) or cytokines were examined in rat vascular smooth muscle cells (VSMC) in culture. 2. CsA inhibited by up to 90% the accumulation of nitrite induced by LPS, but FK506 had a weaker effect on nitrite accumulation induced by LPS in these cells. Both CsA and FK506 (at 1 mumol/L) significantly inhibited nitrite production induced by recombinant murine interleukin-1 beta (rIL-1 beta). 3. Given their differing potency, it is likely that CsA and FK506 suppress induction of NO synthase through different intracellular mechanisms. This action could contribute to the side effects of CsA therapy.
Similar articles
-
Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.Br J Pharmacol. 1999 Sep;128(2):337-44. doi: 10.1038/sj.bjp.0702782. Br J Pharmacol. 1999. PMID: 10510443 Free PMC article.
-
Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells.Hypertension. 1995 Apr;25(4 Pt 2):764-8. doi: 10.1161/01.hyp.25.4.764. Hypertension. 1995. PMID: 7536714
-
Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages.Cell Immunol. 1995 Oct 1;165(1):7-11. doi: 10.1006/cimm.1995.1180. Cell Immunol. 1995. PMID: 7545550
-
Bactericidal/permeability-increasing protein inhibits endotoxin-induced vascular nitric oxide synthesis.Acta Anaesthesiol Scand. 2002 Oct;46(9):1111-8. doi: 10.1034/j.1399-6576.2002.460909.x. Acta Anaesthesiol Scand. 2002. PMID: 12366506
-
Diethyldithiocarbamate ameliorates the effect of lipopolysaccharide on both increased nitrite production by vascular smooth muscle cells and decreased contractile response of aortic rings.Life Sci. 1995;57(2):169-76. doi: 10.1016/0024-3205(95)00257-7. Life Sci. 1995. PMID: 7541501
Cited by
-
Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.J Clin Invest. 1997 Oct 15;100(8):2035-42. doi: 10.1172/JCI119736. J Clin Invest. 1997. PMID: 9329968 Free PMC article.
-
Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.Br J Pharmacol. 1999 May;127(2):498-504. doi: 10.1038/sj.bjp.0702528. Br J Pharmacol. 1999. PMID: 10385251 Free PMC article.
-
Protective effects of cyclosporin-A in splanchnic artery occlusion shock.Br J Pharmacol. 2000 May;130(2):339-44. doi: 10.1038/sj.bjp.0703310. Br J Pharmacol. 2000. PMID: 10807671 Free PMC article.
-
Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.Br J Pharmacol. 1999 Sep;128(2):337-44. doi: 10.1038/sj.bjp.0702782. Br J Pharmacol. 1999. PMID: 10510443 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources